Cargando…
BRCA1 and TP53 codeficiency causes a PARP inhibitor–sensitive erythroproliferative neoplasm
Mutations in the BRCA1 tumor suppressor gene, such as 5382insC (BRCA1(insC)), give carriers an increased risk for breast, ovarian, prostate, and pancreatic cancers. We have previously reported that, in mice, Brca1 deficiency in the hematopoietic system leads to pancytopenia and, as a result, early l...
Autores principales: | Lopez-Perez, Gerardo, Wijayatunge, Ranjula, McCrum, Kelly B., Holmstrom, Sam R., Mgbemena, Victoria E., Ross, Theodora S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869974/ https://www.ncbi.nlm.nih.gov/pubmed/36346676 http://dx.doi.org/10.1172/jci.insight.158257 |
Ejemplares similares
-
Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis
por: Holmstrom, Sam R., et al.
Publicado: (2019) -
brca2 and tp53 Collaborate in Tumorigenesis in Zebrafish
por: Shive, Heather R., et al.
Publicado: (2014) -
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year Period
por: Esterling, Lisa, et al.
Publicado: (2020) -
Surgery for BRCA, TP53 and PALB2: a literature review
por: Song, Chin-Vern, et al.
Publicado: (2018) -
Towards a Therapeutic Reduction of Imatinib Refractory Myeloproliferative Neoplasm-Initiating Cells
por: Philips, Steven T., et al.
Publicado: (2013)